Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154346 · ClinicalTrials.gov registry record
Project Baseline Health Study
A clinical trial of ALL, sponsored by Baseline Study.
- Active
- Registry status
- 10,000
- Enrollment target
- 5
- Study locations
NCT03154346: Active study of ALL, sponsored by Baseline Study.
NCT03154346 is a study of ALL that is active but no longer recruiting, run by Baseline Study. The registered enrollment target is 10,000 participants, above the 192-participant average among 13 other ALL trials with a reported enrollment target (5108% higher). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03154346, a study of ALL, is active but no longer recruiting, sponsored by Baseline Study.
- ACTIVE NOT RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is the first initiative of Project Baseline, a broader effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for disease. Project Baseline endeavors to test and develop new tools and technologies to collect, organize, and activate health information.
Conditions Studied
Study Locations (5)
California
- Baseline Study - South San Francisco
- Stanford Medicine - Stanford
- California Health and Longevity Institute - Westlake Village
North Carolina
- Duke University School of Medicine - Durham
- Duke University School of Medicine - Kannapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2024-12 |
What the registry record for NCT03154346 still lists
NCT03154346 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 192-participant average among 13 other ALL trials with a reported enrollment target (5108% higher).
The record links to 1 condition, with ALL appearing as the primary indexed condition, and to 0 interventions.
NCT03154346 lists 5 locations in 2 states (California, North Carolina).
Frequently Asked Questions
What is clinical trial NCT03154346 about?
NCT03154346 is a clinical study titled "Project Baseline Health Study". This study is the first initiative of Project Baseline, a broader effort designed to develop a well-defined reference, or "baseline," of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for di...
What is the current status of trial NCT03154346?
This trial is currently active not recruiting. The enrollment target is 10,000 participants. The study started on 2017-03-29. Estimated completion is 2024-12.
What conditions does trial NCT03154346 study?
This clinical trial studies the following conditions: ALL.
Who is sponsoring clinical trial NCT03154346?
This trial is sponsored by Baseline Study, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03154346 being conducted?
This trial has 5 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03154346's enrollment target sits among peer trials
10,000 1st of 13 higher than 13 of 13 other ALL trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ALL trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
RECRUITING · Phase 1
-
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RECRUITING · Phase 1
-
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RECRUITING
-
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
RECRUITING · Phase 2
-
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
RECRUITING · Phase 1
-
A Long Term Follow-up Study of TScan TCR-T Products
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI